The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.10
Bid: 0.096
Ask: 0.102
Change: -0.0035 (-3.41%)
Spread: 0.006 (6.25%)
Open: 0.11
High: 0.11
Low: 0.10
Prev. Close: 0.1025
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £400,000

19 Jan 2024 07:00

RNS Number : 2199A
Versarien PLC
19 January 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

19 January 2024

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £400,000

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £400,000 (before expenses) by way of a placing (the "Placing") of 500,000,000 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 0.08 pence per share (the "Placing Price").

 

Highlights

 

· Versarien has raised £400,000, before expenses, through the placing of 500,000,000 new ordinary shares in the capital of the Company at a price of 0.08 pence per share

· The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline whilst continuing to progress its asset sales

· The issue of the Placing Shares is within existing authorities granted by shareholders at the general meeting of the Company held on 10 January 2024 and therefore no shareholder approval is required for the Placing

 

Use of Proceeds and Turnaround Strategy

 

The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline. Recent new projects include a sales agreement with Go To Gym to bring Graphene-WearTM products to Colombia, Brazil and the USA, and Versarien's subsidiary, Gnanomat, entering into an agreement to co-develop advanced materials with IRPC, a Thai petroleum and petrochemical company. These projects, along with a pipeline of other opportunities currently being pursued demonstrate the longer term prospects for the business.

 

As announced on 20 December 2023, the mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020 continue to be marketed for sale and the Company is progressing discussions with a number of interested parties, though the timing of any asset sales and the quantum of the funds that may be received remains uncertain.

 

Stephen Hodge, Chief Executive Officer of Versarien, commented:

 

"In the short time since the Company Update announced on 20 December, the commercial, licencing and grant opportunities have continued to grow. This further funding will help us to progress the conversion of these leads while the asset sale discussions continue. We look forward to updating the market in due course."

 

Admission and Total Voting Rights

 

Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 24 January 2024. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 996,169,507. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGPUGWGUPCPGR
Date   Source Headline
1st Sep 201610:36 amRNSNotice of AGM
3rd Aug 20164:25 pmRNSHolding(s) in Company
2nd Aug 20169:53 amRNSHolding(s) in Company
1st Aug 20168:39 amRNSHolding(s) in Company
28th Jul 20162:01 pmRNSHolding(s) in Company
25th Jul 20167:00 amRNSFully subscribed placing to raise £1.1m
19th Jul 20167:00 amRNSFinal Results
23rd Jun 20167:00 amRNSGraphene Collaboration with CT Engineering
14th Jun 20167:00 amRNSGraphene Collaboration with Absolute Engineering
11th May 20167:00 amRNSGraphene enhanced carbon fibre collaboration
6th Apr 20167:00 amRNSTrading Update
31st Mar 20167:00 amRNS3D Printing with Graphene Trials
11th Mar 20167:00 amRNSResignation of Director
3rd Feb 20167:00 amRNSBoard Changes
11th Dec 20157:00 amRNSDirector Share Purchase
10th Dec 20157:00 amRNSInterim Results
1st Dec 20157:00 amRNSHolding(s) in Company
19th Nov 20157:00 amRNSNotice of Results
4th Nov 20157:00 amRNSChange of Adviser
12th Oct 201511:06 amRNSChange of Registered Office
24th Sep 201511:15 amRNSResult of AGM
21st Sep 20157:00 amRNSVersarien Attending SEC2SV in San Francisco
7th Sep 20157:00 amRNSGrant of US Graphene Patent
19th Aug 20159:53 amRNSAdditional Listing
18th Aug 20152:00 pmRNSPosting of Annual Report
21st Jul 20157:00 amRNSChange of Adviser
21st Jul 20157:00 amRNSFinal Results
13th Jul 20157:00 amRNSCollaboration Between Versarien plc & Haydale plc
23rd Jun 20157:00 amRNSPartnership with UK Graphene Exhibit at NanoKorea
18th Jun 20157:00 amRNSExpansion of European Sales Channels
11th Jun 20157:00 amRNSMajor Advance in Scalable Graphene Production
14th May 20155:16 pmRNSHolding(s) in Company
20th Apr 20157:00 amRNSAppointment of Mouser in Global Distribution Deal
1st Apr 20157:00 amRNSLaunch of standard range of Low Profile Heat Sinks
23rd Feb 20153:12 pmRNSHolding(s) in Company
10th Feb 20157:00 amRNSDirectors' Shareholdings
3rd Feb 20152:00 pmRNSAcquisition
11th Dec 20147:00 amRNSChange of Auditor
11th Dec 20147:00 amRNSInterim Results
21st Nov 20147:00 amRNSMOU with National Graphene Institute
10th Nov 20147:00 amRNSJoint Venture
4th Nov 20147:00 amRNSUpdate on 2-DTech Ltd
3rd Nov 20149:49 amRNSTotal Voting Rights
13th Oct 20143:44 pmRNSExercise of Share Options
7th Oct 20142:37 pmRNSHolding(s) in Company
3rd Oct 20142:19 pmRNSAward of Share Options to Directors
17th Sep 20147:00 amRNSDirectors' Shareholdings
2nd Sep 20143:30 pmRNSDirectorship Disclosures
22nd Aug 20149:34 amRNSResult of AGM
29th Jul 20144:00 pmRNSPublication of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.